Centauri Therapeutics Limited
Research - London, England, United Kingdom
Centauri Therapeutics Limited Employees
Centauri Therapeutics Limited Senior Management
Centauri Therapeutics Limited Details
Centauri Therapeutics Limited is a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life threatening diseases. The Alphamer technology is based on "programmable immunity" in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens to fight the infection. The molecules have two distinct parts: one end binds a cell-surface target on the pathogen using an aptamer whereas the other end presents specific epitopes that attach to the circulating antibodies. It has been demonstrated that Alphamers have the potential to redirect pre-existing antibodies to bacteria in a specific manner and trigger an immediate antibacterial immune response, so clearing the infection. Centauri Therapeutics' assets include specific leads and platform chemistry that is protected by strong IP and a family of granted patents and applications.
Centauri Therapeutics Limited Technologies
Email Providers
Outlook
Load Balancers
Nginx
CMS
WP Engine
Other
Microsoft Office 365
Hosting
Google Cloud Hosting
CSS and JavaScript Libraries
Bootstrap Framework